Skip to content

Axogen AXGN Change in Other Assets

Change in Other Assets at other companies

Baxter International logo
Baxter InternationalBAX
-$2M-108%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$1.04M+61.9%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's change in other assets?
Axogen (AXGN) reported change in other assets of $192K in Q1 2026.
What is the long-term trend for Axogen's change in other assets?
Over 2 years (2021 to 2025), Axogen's change in other assets has grown at a 26.6% compound annual growth rate (CAGR), from -$2.44M to $3.91M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.